Comparison of the Efficacy of Different First-Line Therapies for EGFR L858R-Mutated NSCLC Patients With Brain Metastases.
第一作者:
Jing,Chen
第一单位:
Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
作者:
医学主题词
人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);脑肿瘤(Brain Neoplasms);男(雄)性(Male);女(雌)性(Female);肺肿瘤(Lung Neoplasms);中年人(Middle Aged);蛋白激酶抑制剂(Protein Kinase Inhibitors);老年人(Aged);突变(Mutation);成年人(Adult);回顾性研究(Retrospective Studies);老年人, 80以上(Aged, 80 and over);治疗结果(Treatment Outcome);预后(Prognosis)
DOI
10.1111/cas.70175
PMID
40817635
发布时间
2025-11-03
- 浏览0
Cancer science
3125-3138页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



